Volume 55, Issue 2, February 2005
Leading Articles
Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 135–138, https://doi.org/10.1093/jac/dkh530
Influence of hepatitis B virus genotypes on the response to antiviral therapies
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 139–142, https://doi.org/10.1093/jac/dkh533
Reviews
A review of the microbiology, antibiotic usage and resistance in chronic skin wounds
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 143–149, https://doi.org/10.1093/jac/dkh513
Original Articles
Whole blood-mediated endothelial permeability and adhesion molecule expression: a model study into the effects of bacteria and antibiotics
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 150–156, https://doi.org/10.1093/jac/dkh526
Evaluation of cefoxitin 5 and 10 μg discs for the detection of methicillin resistance in staphylococci
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 157–161, https://doi.org/10.1093/jac/dkh514
Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 162–169, https://doi.org/10.1093/jac/dkh528
Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 170–177, https://doi.org/10.1093/jac/dkh523
Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 178–181, https://doi.org/10.1093/jac/dkh524
Susceptibility of Campylobacter hyointestinalis subsp. hyointestinalis to antimicrobial agents and characterization of quinolone-resistant strains
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 182–187, https://doi.org/10.1093/jac/dkh537
Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 188–193, https://doi.org/10.1093/jac/dkh532
In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002–2003
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 194–199, https://doi.org/10.1093/jac/dkh548
Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 200–208, https://doi.org/10.1093/jac/dkh540
Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 209–213, https://doi.org/10.1093/jac/dkh536
Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 214–222, https://doi.org/10.1093/jac/dkh542
Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 223–228, https://doi.org/10.1093/jac/dkh522
Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 229–233, https://doi.org/10.1093/jac/dkh538
Culture results of heart valves resected because of streptococcal endocarditis: insights into duration of treatment to achieve valve sterilization
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 234–239, https://doi.org/10.1093/jac/dkh527
Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 240–245, https://doi.org/10.1093/jac/dkh531
A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study)
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 246–251, https://doi.org/10.1093/jac/dkh515
BRIEF REPORTS
A specific peptide inhibitor of the class B metallo-β-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 252–255, https://doi.org/10.1093/jac/dkh550
Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 256–259, https://doi.org/10.1093/jac/dkh551
Enhanced resistance to erythromycin is conferred by the enterococcal msrC determinant in Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 260–264, https://doi.org/10.1093/jac/dkh541
In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 265–268, https://doi.org/10.1093/jac/dkh521
Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 269–271, https://doi.org/10.1093/jac/dkh518
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 272–274, https://doi.org/10.1093/jac/dkh545
Correspondence
Fluconazole susceptibility testing of Candida inconspicua clinical isolates: comparison of four methods
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 275–276, https://doi.org/10.1093/jac/dkh539
Activity of a peptide deformylase inhibitor LBM415 (NVP PDF-713) tested against recent clinical isolates from Japan
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 276–278, https://doi.org/10.1093/jac/dkh547
Study of faecal colonization by vanA-containing Enterococcus strains in healthy humans, pets, poultry and wild animals in Portugal
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 278–280, https://doi.org/10.1093/jac/dkh549
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 280–281, https://doi.org/10.1093/jac/dkh516
